Business Daily from THE HINDU group of publications
Monday, March 31, 2008 ePaper | Mobile/PDA Version
|
Business Daily from THE HINDU group of publications Monday, March 31, 2008 ePaper | Mobile/PDA Version |
|
|
|
|
|
|
||
|
News Update as at 18.00 hrs (IST)
Corporate Suven Life Sciences gets two product patents in Korea, Mexico MUMBAI: Suven Life Sciences Ltd has announced that two product patents were granted in Mexico and Korea for two of their new chemical entities (NCEs) for the treatment of disorders associated with neuro-degenerative diseases and these patents are valid u ntil 2023. The patents are exclusive intellectual property of the company and are achieved through the exclusive internal discovery research efforts. Products out of these inventories which are in Pre-clinical development may be out-licensed at the stage of clinica l phase-I or Phase II stage. The granted claims of the patents include the class of selective 5-HT compounds discovered by Suven and are being developed as therapeutic agents. The compounds are useful in the treatment of cognitive impairment associated with neuro-degenerative disord ers like attention deficient hyperactivity, Alzheimer's Parkinson, Schizophrenia and Huntington's.
Prev: Sun Pharma launches cancer drug Business Line | NUS Index | |
Related Topics Alliances & Joint Ventures Announcements Auditing Awards & Honours Bonus Announcements Company Law Corporate Bonds Corporate Disputes Corporate Governance Courts/Legal Issues Diversification Environment Human Resources Interview IPOs IPR Management Mergers & Acquisitions New Projects Open Offers Outlook Outsourcing Overseas Borrowings Overseas Investments People Performance Preferential Allotments Private Placement Regulatory Bodies & Rulings Research & Development Restructuring Rights Issue Sick Units Society & Development Standards & Benchmarks Taxation Trade & Labour Unions |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line
|